Skip to main content

Table 1 Clinicopathologic characteristics (N = 29)

From: Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment

 

patients, n (%)

Subtype I

Subtype II

p value

Age (year)

 Mean

56

54

60

 

 Range

35–73

35–73

41–71

 

Race

 White

20

14

6

 

 Black or African American

4

2

2

 

 Asian

1

1

0

 

 Unknown

4

3

1

 

Tumor weight

   

0.4

 Mean

341.83

303.8

426.33

 

 Range

55–1100

58–1100

55–1077

 

Treatment best response

   

0.04

 Complete Response

8(27%)

6

2

 

 Partial Response

2(7%)

0

2

 

 Clinical Progressive Disease

4(14%)

4

0

 

 Unknown

15(52%)

10

5

 

Metastatic disease confirmed

   

0.18

 YES

10 (34%)

5

5

 

 NO

11 (38%)

9

2

 

 Unknown

8 (28%)

6

2

 

Contiguous organ invaded

   

0.24

 YES

4(14%)

2

2

 

 NO

8 (28%)

7

1

 

 Unknown

17 (58%)

11

6

 

Necrosis percent

   

0.52

 Mean

20.33

23.5

14

 

 Range

0–50

1–50

0–33

 
  1. * p < 0.05